David J. Maloney
Fondateur chez Veralox Therapeutics, Inc.
Profil
David J.
Maloney is the founder of Veralox Therapeutics, Inc. (founded in 2017) where he holds the title of Chief Scientific Officer.
In 2017, he worked as Vice President & Head-Translational Medicine at Rebus Holdings, Inc. Dr. Maloney holds a doctorate from the University of Virginia and an undergraduate degree from the University of Vermont.
Postes actifs de David J. Maloney
| Sociétés | Poste | Début |
|---|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Fondateur | 01/01/2017 |
Anciens postes connus de David J. Maloney
| Sociétés | Poste | Fin |
|---|---|---|
| REBUS HOLDINGS, INC. | Corporate Officer/Principal | 01/12/2017 |
Formation de David J. Maloney
| University of Virginia | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
